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A B S T R A C T   
Negotiations for a new international legally binding instrument under the United Nations Convention on the Law of the Sea for the conservation and sustainable use 
of marine biological diversity of areas beyond national jurisdiction (ABNJ) have commenced. For the new agreement to be fair and effective, it is vital that all States 
are able to participate in the long-term sustainable use and conservation of the ocean beyond national jurisdiction. This includes participation in marine scientific 
research and the utilization of marine genetic resources (MGR) through subsequent innovation processes. Open access to MGR, such as data, coupled with capacity 
building, can promote the equitable sharing of benefits associated with MGR. In this paper, it is hypothesized that an ‘inclusive innovation’ approach may facilitate 
participation and promote enhanced engagement in the conservation and sustainable use of biodiversity beyond national jurisdiction. A number of existing genetic 
resource initiatives provide examples of efforts to foster inclusivity in the innovation process, including BioBricks, Open Source Drug Discovery, GenBank and the 
Global Genome Biodiversity Network. An analysis of these examples enables clear identification of common elements that are adopted by such initiatives, whereby 
inclusive innovation either develops naturally or is promoted actively through measures for open access, capacity building, and collaboration. By empowering more 
States and stakeholders to participate in research and innovation processes, global potential in terms of enhanced scientific knowledge and opportunities associated 
with biodiversity of ABNJ can be promoted and the overall objective of the conservation and sustainable use can be best pursued.   
1. Introduction 
No internationally agreed or legal definition for marine genetic re-
sources (MGR) yet exists. However, a definition can be inferred by 
considering the terms ‘genetic material’ and ‘genetic resource’ as 
defined in the 1992 Convention on Biological Diversity [1]. According to 
Article 2 of the CBD, genetic material is ‘any material of plant, animal, 
microbial, or other origin containing functional units of heredity’. In 
addition, ‘genetic resources’ are defined as ‘genetic material of actual or 
potential value’ (CBD, Article 2). MGR, therefore, could be considered as 
the marine equivalent of these definitions.1 In addition, the President’s 
aid to negotiations (2019) provides a number of potential definitions for 
MGR. MGR represent a source of materials with as-yet largely untapped 
potential, with the capacity to produce high value products. Examples of 
marketed pharmaceutical products derived from marine bioactive 
compounds are listed in Table 1. Due to the rapid progress in techno-
logical fields of marine exploration and laboratory testing, there is sig-
nificant opportunity for discovery of new and possibly valuable genetic 
resources with applications in a number of sectors, ranging from the 
pharmaceutical industry to cosmetics, agriculture, nutraceuticals and 
energy [5,6]. As a result, utilization of MGR has the potential to provide 
benefits to many users. The degree to which this potential is realized will 
depend largely on the manner in which discovery is guided and benefits 
are shared. Other factors to consider include technology, levels of sci-
entific development and commercial viability. 
In 2015, after almost a decade of discussions by informal working 
groups on marine areas beyond national jurisdiction, the United Nations 
General Assembly decided to develop a new international legally 
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binding instrument (ILBI) on biodiversity beyond national jurisdiction 
under the Law of the Sea Convention [7]. A preparatory committee 
began working on this in 2016, and provisions for the agreement were 
reported back to the General Assembly in 2017 [6,8,9]. Formal United 
Nations negotiations for a new ILBI under UNCLOS for the conservation 
and sustainable use of marine biological diversity of areas beyond na-
tional jurisdiction (BBNJ) have now commenced. The first session of the 
Intergovernmental Conference (IGC) convened from 4 to 17 September 
2018, the second from 25 March to 5 April 2019 and the third from 19 to 
30 August 2019. The fourth session is planned to take place in the first 
half of 2020. Negotiations address a ‘package’ of four elements (MGR, 
including questions on the sharing of benefits; measures such as 
area-based management tools (ABMT), including marine protected areas 
(MPAs); environmental impact assessments (EIA), and; 
capacity-building and the transfer of marine technology) and 
cross-cutting issues, as agreed during preparatory committee meetings 
in 2011 (UNGA Res. 69/292, UN Doc. A/Res/69.292, 6 July 2015, para. 
2.). 
It has been recognized that in order for the new agreement to be fair 
and effective, it is vital that all States and stakeholders are able to 
participate in the long-term sustainable use, management and protec-
tion of ocean areas beyond national jurisdiction [12]. This includes 
participation in the utilization of MGR as well as the sharing of potential 
derived benefits. To promote global participation in the utilization of (as 
well as scientific knowledge and opportunities derived from) MGR from 
areas beyond national jurisdiction (ABNJ), a growing body of literature 
suggests that approaches should aim to open up and combine resources, 
as well as create a level playing field in terms of research capabilities 
[10–12]. 
The negotiations for the new agreement present an opportunity to 
aim to address governance of MGR. Open access to marine biological 
samples and data linked to scientific research has been suggested as a 
positive and effective approach to sharing benefits within the context of 
the ILBI. Open access can be defined as ‘releasing samples and data to 
the public domain through openly accessible biorepositories and data-
bases’ [10]. However, this does not necessarily mean free utilization, 
since some restrictions may still apply. Capacity building, encompassing 
scientific training and access to resources, research infrastructure and 
technology, could also be a tool through which benefits can be shared 
[11,41]. Open access and capacity building, therefore, represent two 
important approaches for the equitable sharing of potential benefits 
associated with utilization of MGR. The adoption of open access and 
capacity building measures could offer several advantages [10,11] and 
also lay the foundation for ‘inclusive innovation’ (Fig. 1). 
2. Generating and sharing benefits through inclusive innovation 
In this paper, the term inclusive innovation is intended to encompass 
the definition of open innovation together with a focus on inclusivity. 
Open innovation describes the notion that entities should look for ways 
of ‘tapping into and harnessing the ideas that lie beyond their formal 
boundaries’ in order to benefit from access to a vastly greater pool of 
knowledge, creativity and opportunities [13]. This approach may help 
to accelerate the innovation process. By building on open innovation 
with a focus on inclusivity, the term inclusive innovation can be defined 
as promoting the participation of all relevant stakeholders (including 
developed and developing states, public and private sectors) in inno-
vation processes. With regards to ABNJ, an inclusive innovation 
approach could therefore provide a useful lens to focus efforts, with an 
overarching aim of reducing global inequality in terms of capability to 
participate in the utilization of MGR from ABNJ, as well as associated 
and subsequent innovation processes. Two concepts which could lead to 
inclusive innovation include open access and capacity building. 
An ‘inclusive innovation’ approach can represent an effective avenue 
to facilitate and promote enhanced engagement of all stakeholders in 
aspects associated with use of BBNJ. For example, engaging stake-
holders with a wide variety of expertise during the innovation process 
could generate a feedback loop whereby progressively more benefits are 
generated and shared, more data become openly accessible and capacity 
grows at local and global scales (Fig. 1). This could in turn support ef-
forts to remove barriers (such as access to MGR data, lab facilities, 
research equipment and specific training) that currently prevent or limit 
many developed and most developing States from utilizing MGR from 
ABNJ. In addition, improving marine biodiversity-related knowledge 
from ABNJ would support conservation and sustainable use, maximizing 
opportunities for potential benefits in the form of scientific knowledge 
and innovation opportunities linked to the utilization of MGR from 
ABNJ. 
This paper examines how open access to MGR data, capacity building 
and inclusive innovation can be adopted as important components of 
scientific research and development. Discussions regarding the scope 
and definition of the term ‘MGR data’ are ongoing, and it is not the aim 
of this paper to suggest what this definition should be. For the sake of the 
current paper, MGR data will refer only to raw genetic data and rapidly/ 
automatically generated data [10]. Whilst it is appreciated that both 
MGR samples and data may both be considered as part of ILBI discus-
sions, a detailed examination of MGR sample material is out of the scope 
of the current paper. In this paper inclusive innovation encompasses the 
meaningful participation of (and collaboration with) all relevant States 
and stakeholders, including those who may not necessarily or ordinarily 
have the capacity (i.e. financial resources, knowledge, skills, infra-
structure, technology etc.), to participate in utilization of MGR from 
ABNJ and subsequent innovation processes. 
Lessons and common elements will be drawn from examples of ini-
tiatives that foster inclusivity in the innovation process, including Bio-
Bricks, Open Source Drug Discovery, GenBank and the Global Genome 
Biodiversity Network. In addition, analysis of supporting elements 
within existing genetic resource initiatives will shed light on possible 
ways in which the ILBI could facilitate maximum global engagement in, 
and potential from, utilization of MGR from ABNJ through efforts linked 
to benefit-sharing (Fig. 2). It is not the purpose of the paper to provide 
detailed solutions, rather to propose practical elements of an approach 
for the utilization of MGR in ABNJ to foster open access and capacity 
building, thereby laying the foundation for inclusive innovation through 
the development of the ILBI. In this paper, the focus will be on access to 
and sharing of MGR data. 
Intellectual Property (IP) refers to ‘creations of the mind, such as 
inventions; literary works; designs; and symbols, names and images used 
Table 1 
Marketed pharmaceutical drugs derived from marine bioactive compounds 
extracted from marine organisms (adapted from Refs. [2–4] a.  
Marine organism/ 
species 
Bioactive 
compound 
Application/indication Commercial 
name 
Sponge/Tethya 
crypta 
Cytarabine Treatment of leukemia Cytosar-U® 
Sponge/Tethya 
crypta 
Cytarabine 
liposomal 
Treatment of 
lymphomatous 
meningitus 
Depocyt® 
Sponge/Tethya 
crypta 
Vidarabine Antiviral Vira-A® 
Snail/Conus magus Ziconotide Antiviral Prialt® 
Sea squirt/ 
Ecteinascidia 
turbinate 
Trabectedin Antitumoral Yondelis® 
Sponge/ 
Halichondria 
okadai 
Eribulin 
mesylate 
Antitumoral Halaven®  
a https://www.eisai.com/news/news201610.html. 
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in commerce’ IP can be legally protected, for example with patents, 
copyright or trademarks, allowing people to receive recognition or 
financial benefit from their inventions.2 IP issues are dealt with under 
relevant IP instruments, including World Intellectual Property Organi-
zation (WIPO) treaties such as the Patent Cooperation Treaty (PCT) and 
the WIPO Copyright Treaty (WCT).3 However, access to and use of ge-
netic resources are dealt with by access and benefit-sharing (ABS) 
mechanisms under the Nagoya Protocol on Access to Genetic Resources 
and the Fair and Equitable Sharing of Benefits Arising from their Utili-
zation to the Convention on Biological Diversity (29 October 2010, 
entered into force 12 October 2014). At present, it remains unclear the 
Fig. 1. Representation of how open access to MGR 
data together with capacity building could pave the 
way for inclusive innovation in terms of associated 
policy and practice. The top bar indicates the high- 
level, policy requirements to be considered during 
negotiations for the new agreement. The overarching 
objective of the new agreement will be the ‘conser-
vation and sustainable use of marine biological di-
versity of areas beyond national jurisdiction’. A key 
element (as part of a ‘package’ of elements to be 
considered) within the agreement encompasses 
‘MGR, including questions on the sharing of benefits’. 
Global potential from MGR from ABNJ could be 
facilitated through efforts linked to benefit-sharing. 
Open access and capacity building represent two 
important tools through which benefits could be 
shared. The bottom bar indicates how the policy 
could be implemented and put into practice.   
Fig. 2. A and B) Two possible approaches (indicated 
by the dashed and solid lines) could be taken for 
generating scientific knowledge, opportunities and 
wealth from MGR from ABNJ, by A) emerging, and B) 
established MGR States. The size of the middle circles 
represents current capability to utilize MGR from 
ABNJ, as well as knowledge and overall capacity for 
conservation and sustainable use of BBNJ. Bold, solid 
line: status quo/without ILBI – does not encourage 
inclusive innovation. Emerging and established MGR 
States grow slightly in terms of capability to utilize 
MGR from ABNJ, scientific knowledge, opportunities 
and wealth. Bold, dashed line: open access, capacity 
building and inclusive innovation – maximum po-
tential growth in capability for both emerging and 
established States, as well and knowledge and ca-
pacity. All stakeholders/States have the opportunity 
to benefit. C). Two possible approaches for generating 
global (emerging plus established MGR States) sci-
entific knowledge, opportunities and wealth from 
MGR from ABNJ. Bold, solid line: status quo/ 
without ILBI – does not encourage inclusive inno-
vation. Emerging and established MGR States grow 
slightly in capability. Global potential increases 
slightly. Bold, dashed line: open access, capacity 
building and inclusive innovation – maximum 
possible growth in capability for both emerging and 
established MGR States (in terms of generating sci-
entific knowledge, opportunities and wealth). Global 
potential increases greatly (and to a greater extent 
than with the other two approaches), therefore all 
States have the opportunity to benefit. D) Potential 
benefits to be shared from utilization of MGR from 
ABNJ, according to status quo/without ILBI and 
according to the open access, capacity building 
and inclusive innovation approach.   
2 https://www.wipo.int/treaties/en. 
3 http://www.science-international.org/sites/default/files/reports/open-dat 
a-in-big-data-world_long_en.pdf. 
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extent to which IP will be addressed within the ILBI, and so the inter-
action between the ILBI and various WIPO treaties cannot yet be 
determined. Article 12 within the draft text of a BBNJ agreement refers 
to IP and makes general statements such as ‘States Parties shall imple-
ment this Agreement in a manner consistent with the rights and obli-
gations of States under the relevant agreements concluded under the 
auspices of the World Intellectual Property Organization and the World 
Trade Organization’ (June 2019). However, it is important to note that 
central components related to IP (which may potentially be linked to 
MGR of ABNJ) will be dealt with under the relevant IP instruments. 
The authors acknowledge that IP and associated rights and re-
strictions exist, and that these are fundamental for potential develop-
ment of products (such as pharmaceuticals) from MGR of ABNJ. Open 
access to MGR data is important for research and development (R&D) 
for commercial purposes, and patenting of inventions resulting from use 
of open access MGR data can help to drive innovation [14]. In addition, 
IP rights play an important role within the biotechnology business 
model, in order to secure return on (financial) investment, and are also 
crucial with regards to how biotechnology R&D is funded. However, 
whilst it is recognized that IP law plays an important role in the way that 
MGR from ABNJ will be utilized and regulated, the authors do not intend 
to make any statements that may affect the use or existence of IP rights 
(including patents). Therefore, a detailed review of IP law and its 
interaction with MGR is out of the scope of this paper. 
3. Open access and capacity building 
3.1. Open data 
The concept of ‘open data’ could be an important way of focusing on 
open access with specific reference to data. Open data must be ‘intel-
lectually open’, indicating that data can be thoroughly scrutinised and 
re-used as is appropriate [15]. ‘Open Data in a Big Data World’4 suggest 
that a specific list of criteria (see Table 2) should be satisfied in order to 
classify data as open. 
According to Science International (2015), ‘open data should be the 
default position for publicly funded science’ and is critical for ensuring 
that all of society can benefit [9].5 Therefore, an assessment of existing 
scientific good practices with regards to the way that data is stored, 
accessed and shared in current, open access organizations/projects 
would be useful for BBNJ negotiations and for determining how 
data-sharing can be improved. 
Open access to MGR data is important for R&D and can help to drive 
innovation. This approach could be represented by the bold, solid arrow 
(status quo/without ILBI) in Fig. 2, whereby innovation is encouraged to 
a degree, but not to the extent it could be if capacity building and in-
clusive innovation were also adopted. As a result, both emerging and 
established MGR user States6 grow slightly in terms of capability to 
utilize MGR from ABNJ and to develop scientific knowledge, opportu-
nities and wealth. However, as also indicated by Blasiak, et al. (2018), in 
order to promote inclusion of a greater number and variety of stake-
holders, open access must be accompanied by capacity building. This 
approach is depicted by the bold, dashed arrow (open access, capacity 
building and inclusive innovation) in Fig. 2 and may facilitate maximum 
possible growth of capability for both emerging and established MGR 
user States (in terms of generating scientific knowledge, opportunities 
and wealth), as well as potential in terms of conservation and sustain-
able use of BBNJ. As a result, all States may have a greater opportunity to 
benefit from utilization of MGR from ABNJ. 
3.2. Open access to MGR data and associated capacity building 
Open access to MGR data is vital for providing everyone around the 
world, regardless of location or economic status, with opportunities to 
conduct R&D on MGR [9,10,12]. Open access also emerged during 
Preparatory Committee sessions (meetings held in preparation for the 
IGC) as an important tool for sharing of benefits derived from utilization 
of MGR from ABNJ and could be a key element for the ILBI. To a certain 
degree, the scientific community already implements in practice the 
concept of open access to data from ABNJ [10]. For example, it is a 
common requirement for publicly funded institutions to deposit taxo-
nomic and genetic data in public databases [16]. 
However, uneven levels of access to MGR data from ABNJ still exist 
between countries [17]. This disparity is due mostly to the scientific 
skills needed to conduct research on marine biodiversity, the cost and 
scientific skills needed to undertake molecular screening and biodiver-
sity assessment, and the scientific skills needed to analyse the data 
produced. There is, therefore, clearly a strong link between disparity in 
access to MGR data and the need for capacity building [17]. Efforts 
linked to capacity development in terms of MSR could therefore enable a 
greater number of States to take part in the utilization of MGR. Ac-
cording to Mohammed [12]; capacity building and technology transfer 
under a new treaty should ‘enhance least developed countries’ ability to 
identify, assimilate, transform and apply scientific knowledge and 
technological knowhow’. 
3.3. Key elements for open access and capacity building in existing genetic 
resource initiatives 
Factors which contribute towards facilitating open access to genetic 
resource data and capacity building can be identified through an anal-
ysis of existing genetic resource initiatives (Table 3). Key elements 
include: low-cost, openness (section 2.2.1); long-term infrastructure 
(section 2.2.2) and other tools (section 2.2.3). These elements could 
facilitate engagement in, and potential benefits from, utilization of MGR 
from ABNJ - paving the way for inclusive innovation as an approach to 
utilization of MGR from ABNJ (Section 3). 
3.3.1. Low-cost and open to all 
Low-cost access to and retrieval of data is a critical factor in the 
operation of open access initiatives. Access to data may be via freely 
accessible databases, with either free or low-cost access to data, which 
could then potentially be used to synthesise material in laboratories. 
Low-cost access with limited burdens can promote widespread use of 
data by all interested parties, irrespective of location, status or capacity. 
The ‘The Earth Microbiome Project’ (EMP), as described by Thompson, 
et al. [18] is an example of an initiative which embraces the low-cost 
Table 2 
List of criteria which should be satisfied in order to classify data as open data.a.  
Criteria Description of criteria 
Discoverable a web search can readily reveal their existence 
Accessible the data can be electronically imported into or accessed by a 
computer 
Intelligible there must be enough background information to make clear the 
relevance of the data to the specific issue under investigation 
Assessable users must be able to assess issues such as the competence of the data 
producers or the extent to which they may have a pecuniary interest 
in a particular outcome 
Useable there must be adequate metadata (the data about data that makes it 
useable), and where computation has been used to create derived 
data, the relevant code, sometimes together with the characteristics 
of the computer, needs to be accessible  
a http://ocw.metu.edu.tr/pluginfile.php/4339/mod_resource/content/0/ 
week3content.pdf. 
4 http://www.science-international.org/.  
5 The term ‘emerging and established MGR States’ in this paper refers to the 
degree to which States are currently capable of utilizing MGR from ABNJ. 6 https://biobricks.org/bpa/developers/. 
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open access approach. Such data can then be further annotated by the 
research community. 
The BioBricks foundation, a specific brand of genetic, interchange-
able parts, was established in 2006 with the mission to ‘ensure that the 
engineering of biology is conducted in an open and ethical manner to 
benefit all people and the planet’.7 BioBricks developers also initiated 
the iGEM foundation – an International Genetically Engineered Machine 
Competition. Physical DNA in the form of non-patented genes are sent to 
users by the BioBricks foundation for a small handling fee. In case users 
are able to synthesise their own material (such as DNA), using freely 
available code data from the BioBricks and iGEM databases and web-
sites, then no costs are involved (since no material parts need to be sent 
out).8 By keeping costs to a minimum, the potential number of re-
searchers from States at all levels of development who are able to access 
and use the BioBrick parts is maximized. 
Other highly relevant examples of open access, genetic resource 
initiatives include GenBank and the Global Genome Biodiversity 
Network (GGBN). The GenBank database holds a collection of all pub-
licly available (hence open access) DNA sequences, whilst the GGBN 
represents a network of institutions aiming to preserve and share 
genomic samples. However, the distinction must be made between da-
tabases that are open access (such as GenBank and BIOS) and associa-
tions of scientists (such as the GGBN) which adopt an open access policy 
with regards to genetic materials. Whilst both of these initiatives pro-
mote open access, the sharing of data is easier and usually cheaper than 
the physical sharing of genetic sample material. This is partly because 
data can be shared instantly online via internet databases/data portals 
and does not require the packaging and shipping of physical material, 
but also due to the finite nature of material which does not apply to data. 
Therefore, whilst sharing of sample material will undoubtedly be 
important, the sharing of MGR data can be seen as a more immediate 
and more straight-forward form of access to MGR and also of benefit- 
sharing. 
The Biological Innovation for Open Society (BIOS) is another 
initiative working to ensure that data related to patents is openly 
accessible. BIOS is an open-access patent database which collates IP data 
from several national patent offices, with the objective of improving the 
process of interpreting and filtering IP [19].9 This helps users search for 
patents filed at various national and international patent offices. 
3.3.2. Long-term infrastructure 
Information communication technology (ICT) can be used to enable 
easy access to data. Open online platforms are a type of ICT infrastruc-
ture that are utilized in this way. BioBricks is an initiative which makes 
Table 3 
Existing genetic resources initiatives which foster open access and capacity 
building.  
Genetic 
Resource 
Initiative 
Description Elements for 
open access 
Elements for 
capacity building 
GenBank The National 
Institute of Health 
genetic sequence 
database, an 
annotated 
collection of all 
publicly available 
DNA sequences 
Low cost and 
open to all 
Educational 
activities/ 
knowledge transfer 
and training 
Global Genome 
Biodiversity 
Network 
(GGBN) 
An international 
network of 
institutions that 
share an interest in 
long-term 
preservation of 
genomic samples 
representing the 
diversity of non- 
human life on Earth 
Low cost and 
open to all 
Educational 
activities/ 
knowledge transfer 
and training 
Biological 
Innovation 
for Open 
Society 
(BIOS) 
An open-access 
patent database 
which collates IP 
data from multiple 
national patent 
offices, with the aim 
of improving the 
process of 
interpreting and 
filtering IP 
Low cost and 
open to all 
Educational 
activities/ 
knowledge transfer 
and training 
BioBricks An information 
technology system 
with 
interchangeable 
parts, developed 
with the aim of 
building biological 
systems in living 
cells 
Low cost and 
open to all. 
Long-term 
infrastructure 
Educational 
activities/ 
knowledge transfer 
and training 
International 
Genetically 
Engineered 
Machine 
Competition 
(iGEM) 
An independent, 
non-profit 
organization 
dedicated to the 
advancement of 
synthetic biology, 
education and 
competition, and 
the development of 
an open community 
and collaboration 
Low cost and 
open to all. 
Long-term 
infrastructure 
Educational 
activities/ 
knowledge transfer 
and training. 
Entrepreneurship 
Open Source 
Seed 
Initiative 
(OSSI) 
An organization 
that maintains a 
mechanism through 
which plant 
breeders can openly 
access plant genetic 
resources 
worldwide 
Long-term 
infrastructure 
Educational 
activities/ 
knowledge transfer 
and training. 
Entrepreneurship 
Open Source 
Drug 
Discovery 
(OSDD) 
A global, 
translational 
platform for drug 
discovery where 
‘the best minds can 
collaborate & 
collectively 
endeavor to solve 
the complex 
problems associated 
with discovering 
novel therapies’ 
Long-term 
infrastructure. 
Attribution 
Educational 
activities/ 
knowledge transfer 
and training 
Global Open 
Data for 
Agriculture 
A group of partners 
which support ‘the 
proactive sharing of 
Low cost and 
open to all 
Educational 
activities/  
Table 3 (continued ) 
Genetic 
Resource 
Initiative 
Description Elements for 
open access 
Elements for 
capacity building 
and Nutrition 
(GODAN) 
open data to make 
information about 
agriculture and 
nutrition available, 
accessible and 
useable’ 
knowledge transfer 
and training 
The Earth 
Microbiome 
Project (EMP) 
A collaborative 
effort to collect 
microbial samples 
and data across the 
biomes and habitats 
of our planet 
Low cost and 
open to all 
Educational 
activities/ 
knowledge transfer 
and training  
7 http://parts.igem.org/Main_Page.  
8 http://www.bios.net/daisy/bios/home.  
9 http://parts.igem.org/Help:An_Introduction_to_BioBricks; http://igem.org 
/Software. 
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use of a long-term, sustainable ICT system and open source software10. 
The BioBrick parts (or building blocks) are physical material (such as 
standardized DNA sequences and genes) as well as coding information, 
which users can access to synthesis their own physical material. These 
parts can be built and incorporated into living cells, such as E. coli, and/ 
or used to design and assemble larger synthetic biological systems [20]. 
In order11 to achieve this, BioBricks maintains an open source, shared 
publishing platform for scientific research that people from both 
academia and industry can use, while still allowing a system with a 
certain degree of ownership to be built on this open platform. This is 
similar to open source software. Open source can be described as ‘a 
subset of free software that is made available under a copyright license 
approved by the Open Source Initiative as conforming with the Open 
Source Definition’.12 Open source software is strict since it requires that 
any new software built on the existing open source software must also be 
open source. The open source nature is, therefore, maintained and can 
be described as ‘viral’ [21]. The concept of ‘open source’ began as a 
movement within the software industry in the early 1990’s and devel-
oped over time into a business model [22]. The best-known product of 
the open source model is Linux, an alternative operating system to 
Microsoft’s Windows. Building on the Linux concept, biologists started 
creating open source bioinformatics tools for data mining, visualization, 
simulation, statistics, integration and analysis [23]. Open source in this 
context then refers to the open origin of contributors as opposed to the 
source code [22]. In other words, biological open source models are 
based on a community of participation [24,25]. Open source R&D is an 
approach which enables scientists to work together across organizations, 
disciplines and borders, with the aim of solving problems in which they 
all share a common interest [22]. As such, long-term infrastructure to 
support inclusive innovation could be inspired by open source. How-
ever, it is noted that open source regarding software may not necessarily 
be directly applied to situations in highly regulated sectors or industries. 
3.3.3. Attribution 
Patents today are typically used to protect IP and to secure a return 
on (financial) investment. However, patents also serve the role as a tool 
to share information and enable benefit-sharing (i.a. through licensing). 
This role could be explored more in the future. Tools, such as attribution, 
are recognized as important elements in encouraging open access to 
data. Attribution is way in which to copy, distribute, display and 
perform work and also to acknowledge the author/licensor/inventor for 
it (e.g. indicating ‘by author x’) [26]. Some scientists view attribution as 
an important reward of science [27]. These tools can therefore be useful 
for promoting the sharing of and open access to data. 
According to Sugumaran [28]; the ‘OSDD aspires to use patents as a 
tool for attribution rather than a means of revenue-generation’. 
Micro-attribution is a mechanism used by the OSDD which enables in-
dividual contributions of information to be tracked using patented in-
formation that is submitted and used by the online virtual system [28]. 
Patents are therefore used as a tool for attribution, encouraging the 
sharing and wider dissemination of information, and could also be seen 
as an important means of tracking benefit-sharing. Patents promote 
disclosure as patented information is readily available through patent 
databases. These databases potentially provide a straightforward way of 
maintaining open access to data, though not the right to utilize the 
innovation developed by the patent owner, unless the patent owner 
agrees or until the 20-year exclusivity period is over. 
4. Inclusive innovation 
4.1. Operationalizing inclusive innovation with regards to utilization of 
MGR from ABNJ 
In order for open access to MGR from ABNJ to become a reality in 
practice, scientific networks need to strengthen and grow [11]. Bio-
repositories and databases will need to become better linked so that 
difficulties and burdens currently associated with access are reduced. 
Effective capacity building in this particular situation will involve 
knowledge transfer together with targeted training or education pro-
grammes [9]. The combination of open access and capacity building 
efforts could remove some currently existing barriers for States in terms 
of capability to conduct scientific R&D on MGR from ABNJ. This will be 
discussed further in section 4. Clear provisions for open access together 
with capacity building could lay the foundation for inclusive innovation 
with regards to utilization of MGR from ABNJ. 
4.2. Structural elements supporting inclusive innovation in existing genetic 
resource initiatives 
As with open access (and capacity building), potential key elements 
which may encourage inclusive innovation can be identified through the 
analysis of existing genetic resource initiatives (see Table 4), such as 
those described in section 3.3. The aim of the following discussion is to 
look beyond these examples with a view to identifying elements of in-
clusive innovation in existing genetic resource initiatives that could 
provide inspiration and potentially be adopted through a BBNJ agree-
ment as part of a benefit-sharing mechanism for MGR. 
4.2.1. Appropriate IP sharing arrangements, including Creative Commons 
licensing 
In order to promote participation and collaboration in MSR linked to 
MGR, it is important that data can be shared. Licensing has emerged as 
an appropriate approach for application and sharing of data derived 
from MSR and marine bioprospecting [29]. Licensing refers to the 
management of IP assets in a specific way that enables dissemination of 
innovation according to pre-defined terms. Creative Commons licenses, 
Table 4 
List of existing genetic resources initiatives which adopt principles of inclusive 
innovation.  
Genetic 
Resource 
Initiative 
Description Elements for inclusive 
innovation 
BioBricks An information technology 
system with interchangeable 
parts, developed with the aim of 
building biological systems in 
living cells 
Public domain approach 
Open Source 
Seed 
Initiative 
(OSSI) 
An organization that maintains 
a mechanism through which 
plant breeders can openly 
access plant genetic resources 
worldwide 
Appropriate IP protection 
arrangements, including 
(creative commons) licensing 
Open Source 
Drug 
Discovery 
(OSDD) 
A global, translational platform 
for drug discovery where ‘the 
best minds can collaborate & 
collectively endeavor to solve 
the complex problems 
associated with discovering 
novel therapies’ 
Appropriate IP protection 
arrangements, including 
(creative commons) 
licensing. 
Generation of knowledge in a 
cumulative, cooperative, 
collaborative and inclusive 
manner, such as through the 
use of Public Private 
Partnerships (PPP) and Open 
Collaboration. 
Public domain approach. 
Online communities and 
networks  
10 http://ocw.metu.edu.tr/pluginfile.php/4339/mod_resource/content/0/ 
week3content.pdf.  
11 https://opensource.org/node/878.  
12 https://creativecommons.org/about/. 
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defined as non-exclusive, non-revocable public copyright licenses, 
facilitate the legal sharing, reuse and possibly also the free distribution 
of ‘knowledge and creativity to build a more equitable, accessible, and 
innovative world’13 [26]. This is conducted in accordance with terms 
that are flexible and legally sound. Creative Commons licenses provide a 
‘way to manage the copyright terms that attach automatically to all 
creative material under copyright’.14 In other words, authors can grant 
people the right to share, use and build upon their own work [26]. In 
terms of MGR, this may, for example, apply to databases and in cases 
where DNA sequences are annotated or labelled. 
Licensing, as a means by which IP owners can choose to exercise 
their rights, can be seen to remove the barriers that some people may 
expect to encounter when working with IP protected data. As a result, 
licensing could promote the engagement and collaboration of a greater 
number of people in the R&D process, thereby facilitating and encour-
aging inclusive innovation. Additional, potential advantages associated 
with the use of licenses, together with a collaborative sharing framework 
and variety of motivated participants, include the fact that benefits can 
accrue locally (such as treatments for local diseases, improved health, 
employment and payment of tax to the local state). 
In certain cases, such as for neglected diseases, the OSDD system 
could have value. Whilst partners to the OSDD are free to patent as they 
wish, sharing of results in the public domain is encouraged. The OSDD 
‘promotes patenting based on the general public license that ensures that 
the subsequent innovations which follow on from the existing patent 
remain openly accessible through the OSDD community through its viral 
clauses’ [28].15 This approach limits exclusion from accessing or using 
the public information [26,28]. In addition, this approach promotes 
affordability and accessibility by ensuring that pharmaceutical products 
and treatments for neglected diseases are licensed non-exclusively. 
4.2.2. Generation of knowledge in a cumulative, cooperative, collaborative 
and inclusive manner, such as through the use of public private partnerships 
(PPP) and Open Collaboration 
The generation of scientific knowledge in a manner that is cumula-
tive, cooperative, collaborative and inclusive may help to encourage 
inclusive innovation with regards to utilization of MGR from ABNJ. This 
form of knowledge creation may be facilitated through the use of PPPs 
and Open Collaboration. Whilst there is no single definition, the term 
PPP is generally interpreted as referring to ‘forms of cooperation be-
tween public authorities and the world of business which aim to ensure 
the funding, construction, renovation, management or maintenance of 
an infrastructure or the provision of a service’ [30]. PPPs are an 
approach towards IP management which encourages the participation of 
a variety of stakeholders [26]. Open access as part of a structured entity, 
such as a PPP, can enable open access to have more impact than a 
stand-alone open access database and can also be seen as the oper-
ationalization of capacity building. For example, by interacting with 
PPPs, open access can become more collaborative. PPPs provide a 
format to meaningfully engage the private sector and can be a tool to 
bring innovative finance into ABNJ [31]. Motives for participation in a 
PPP differ. Whilst academic researchers may focus more on publication 
of results, the private sector will aim to generate profits and return on 
investment [32,33]. A common PPP focus is on the sharing and pooling 
of complementary skills [26]. 
4.2.3. Public domain approach 
A public domain approach has been identified as an element within 
existing genetic resource initiatives which may promote inclusive 
innovation. This approach can be used when there is no need or desire to 
control access, or when access is open. The term ‘public domain’ 
therefore indicates that nobody can be excluded from having access to or 
using data that are in the public domain [26]. Genetic resource data in 
the public domain may include previously patented products/processes 
(once the patent right has expired), products/processes which are not 
patented, as well as those for which a patent has been declined.16 A 
public domain approach is achieved when samples and related data are 
shared publicly, eventually through international networks of bio-
repositories or international networks with established databases 
creating common pools [10]. The BioBricks Foundation uses such an 
approach, with a mission to ‘ensure that the engineering of biology is 
conducted in an open and ethical manner to benefit all people and the 
planet’. The OSDD initiative also uses the public domain approach to 
benefit-sharing. Advantages of the public domain approach (together 
with open access) include low monetary costs, local accrual of benefits 
(such as access to resources or development of solutions to local chal-
lenges), greater innovation, transparency and openness. 
4.2.4. Online communities and networks 
In order for stakeholders to work together and participate in inclu-
sive innovation, ICT infrastructure is needed to support the establish-
ment of online communities and associated collaborations [24,25]. 
Data, new discoveries and applications have little inherent use unless 
they can be utilized in the search for solutions to challenges. To help find 
these solutions, the OSDD and the Council of Scientific and Industrial 
Research (CSIR), India, partnered with an ICT company to develop a 
search engine-based portal.17 The aim of the portal is to enable re-
searchers to form collaborative online networks, with potential to create 
virtual, distributed laboratories for furthering R&D associated with 
discovery and development of new drugs to treat Tuberculosis [25]. The 
portal integrates social networking with scientific workflows, giving all 
people involved the opportunity to interact in a way that is simple and 
which promotes effective dialogue that can lead to progress towards the 
research objectives [24,25]. This form of global collaboration and 
engagement with a vast community of other researchers, as permitted by 
the existence of the online portal, provides a valuable tool for promoting 
inclusive innovation. 
5. ILBI negotiations: embracing clear provisions for open access 
and capacity building, thereby paving the way for inclusive 
innovation 
5.1. Open access and capacity building in the ILBI 
Clear provisions for open access to MGR data, together with associ-
ated capacity building, will be required to implement the ILBI. This 
could lead naturally to inclusive innovation. Key elements for open ac-
cess, capacity building and inclusive innovation in existing genetic 
resource initiatives have been identified and demonstrate the merits of 
this type of approach. However, MGR from ABNJ present a different case 
compared to genetic resources within national jurisdiction. Key ele-
ments (such as low-cost and open to all, long-term infrastructure and 
attribution) can be used as a starting point, to identify potential solu-
tions that could inspire and underpin the inclusive innovation approach. 
Broggiato, et al. (2018) suggest a regime for sharing benefits from MGR 
that would promote open access to data while keeping the burden on 
users (and providers) to a minimum. In other words, access could be free 
of restrictions (such as excessive access tolls), but the procedure may be 
accompanied by the requirement to record a minimum amount of in-
formation, together with potential benefit-sharing obligations. This 
would not assume ownership of data, but would be more concerned with 
the rights to use it and enabling open access to data. 
Aspects to consider during ILBI negotiations could include the 
13 https://creativecommons.org/faq/#what-are-creative-commons-licenses.  
14 http://www.osdd.net/.  
15 https://opensource.org/node/878. 
16 http://sysborg2.osdd.net/web/guest.  
17 http://www.iobis.org/. 
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following points: 
A) Introduction of means to coordinate, strengthen and support 
global research and data connections 
A large amount of marine-related data already exists in open, online 
databases. By coordinating, strengthening and supporting global con-
nections between various existing biorepositories and databases, MGR 
could become increasingly open and accessible [10]. Support for data 
repositories, including existing systems, to host and share data from 
ABNJ will be important for sharing benefits, including by providing 
information on where data can be found and how to access them. The 
Ocean Biogeographic Information System (OBIS) is ‘a global open-access 
data and information clearing-house on marine biodiversity for science, 
conservation and sustainable development’.18 OBIS represents a suitable 
existing platform for hosting and sharing data from BBNJ and, in some 
regards, already fulfils this role19. A key strength of OBIS is its inter-
national network of national and regional nodes, and the coordination 
within IOC-UNESCO. However, in order to provide a long-term solution 
for MGR benefit-sharing, OBIS would likely require additional resources 
[34]. 
B) Coupling of open access to MGR data with capacity building 
Open access to MGR data could be coupled with capacity building, 
such as access to equipment, training and long-term support for infra-
structure to level the playing field and to provide all States with fairer 
opportunities in terms of capability to utilize MGR from ABNJ. Doing so 
would provide a solid foundation for inclusive innovation and support of 
benefit-sharing under an ILBI. 
5.2. Strengths of the inclusive innovation approach 
An approach which harnesses open access, capacity building and 
inclusive innovation has great potential in terms of promoting mean-
ingful participation of, and collaboration with, many States/stake-
holders in the sustainable utilization of MGR from ABNJ. In addition, 
this approach could enhance global marine scientific knowledge, 
accelerate the rate of discoveries and R&D project development, and 
facilitate the equitable sharing of benefits. 
5.2.1. Facilitating greater participation of states and stakeholders in the 
utilization of MGR from ABNJ 
A working environment which fosters the concepts of open access, 
capacity building and inclusive innovation could facilitate the engage-
ment of a greater number and diversity of States/stakeholders in the 
R&D process associated with MGR from ABNJ. This has the potential to 
reduce disparity between States in terms of differential access capabil-
ities [35]. In addition, open access coupled with capacity building, could 
encourage participation in the inclusive innovation process by removing 
potential barriers that might be associated with capability to conduct 
R&D on MGR. 
5.2.2. Enhancing global scientific knowledge, opportunities and wealth with 
regards to MGR from ABNJ 
An open innovation approach, whereby access to data and capacity 
building form key pillars of benefit-sharing, could offer advantages such 
as enhancing capability to utilize MGR, as well as scientific knowledge, 
opportunities and wealth associated with utilization of MGR from ABNJ 
(see Fig. 2). 
5.2.2.1. Scientific knowledge. It is thought that a high diversity of MGR 
exists in ABNJ, a large proportion of which has yet to be identified. 
Combining open access, capacity building and inclusive innovation 
could help to broaden and speed up the process of discovery and product 
development. This would enable (marine) scientific research to advance 
at a scale and rate that would simply not be possible with a more 
restrictive, less inclusive and less open access regime. By conducting 
research on a wider variety of material and in collaboration with a larger 
number of diverse partners, the rate and probability of genetic resource 
discoveries with implications for new, life-enhancing and/or commer-
cially viable products would be enhanced [10]. For example, enhanced 
scientific R&D could have a direct impact on the number and variety of 
pharmaceutical products available to civil society in the near future. In 
addition, inclusive innovation could create a feedback loop that in-
creases basic scientific knowledge regarding BBNJ, that could in turn 
promote conservation and sustainable use of BBNJ by supporting suc-
cessful establishment of ABMT such as MPAs. 
5.2.2.2. Opportunities (local and global). The approach outlined in this 
paper will provide critical advantages for a number of important, global 
issues. By promoting the participation of researchers, professionals, 
students and teachers around the world, it is possible to leverage 
expertise in order to facilitate particular objectives, such as finding cures 
to some of the world’s most deadly diseases or understanding how best 
to protect different parts of the ocean [36]. Tapping into this vast 
resource at the global scale provides unique and valuable opportunities 
[24,25]. Inclusive innovation would also promote streamlining of local 
expertise into R&D, thereby fostering local needs. In turn, a variety of 
benefits could be provided for a number of different sectors linked to 
science, business and also society [24,25]. 
5.2.2.3. Inclusive wealth. By facilitating and advancing global innova-
tion on the basis of effective knowledge generation, economic value 
could potentially be created. Inclusive participation and collaboration in 
this process may provide successful outcomes for all parties involved, as 
they have the chance to benefit not only from the products developed, 
but also from the knowledge transfer and the opportunities associated 
with participating in the process itself. Enhanced information-sharing in 
this form has been shown to encourage discovery and in turn benefit the 
entrepreneur [37]. Just as in the case of cooperation between smaller 
and larger enterprises, pursuing entrepreneurship collaboratively allows 
parties to preserve their creativity and flexibility [38]. Therefore, both 
emerging and established MGR user States could potentially benefit 
from the innovation potential (as illustrated in Fig. 2. A, 2. B and 2. C) if 
the ILBI provides a common framework to support joint exploration of 
the results. 
The private sector could also stand to gain from open access and 
inclusive innovation. Since the probability of discovering a genetic 
resource with true potential for commercialization and financial reward 
is slim, inclusivity and collaboration with a variety of different partners 
could improve the odds and play an important role in promoting their 
success [39,40]. 
5.2.3. Promoting more equitable benefit-sharing 
As inclusive innovation becomes established, it could become self- 
perpetuating due to the creation of a feedback loop (see Fig. 1). The 
process of inclusive innovation will help to improve further utilization of 
MGR due to enhanced knowledge creation together with refinement of 
techniques, methodology and equipment. As a result, the quality and 
quantity of generated benefits could be improved. This is depicted in 
Fig. 2.D.i and .D.ii, with the size of the benefit-sharing bubble becoming 
larger as a result of open access, capacity building and inclusive inno-
vation. These benefits could potentially then be shared in a more equi-
table manner, to further facilitate participation in inclusive innovation 
(G7 people-centered action plan on innovation, skills and labor, 2017). 
These benefits may be realized through capacity building and by 
providing a wider variety of projects for any given state/stakeholder to 
participate in. 
18 http://www.iobis.org/. 
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6. Conclusion 
By providing all States and stakeholders with open access to MGR 
data, together with the required capacity building (needed to equip 
parties with the capability to conduct R&D on these resources), barriers 
which currently limit utilization of MGR from ABNJ could be dimin-
ished. Open access and capacity building are crucial elements for in-
clusive innovation that support benefit-sharing from genetic resources. 
Incorporating robust measures for these elements into the ILBI would lay 
the foundation for an inclusive innovation approach to utilization of 
MGR from ABNJ, which could enable the meaningful participation of a 
greater number and variety of States/stakeholders. Such an approach 
could support a range of outcomes, from enhancing scientific knowl-
edge, creating new opportunities to participate in R&D and share in the 
benefits from genetic resources. Open access, capacity building and in-
clusive innovation will not be the whole answer in terms of utilization of 
MGR from ABNJ, but implementation of this concept could enable a 
broad range of States (and the global community as a whole) to 
participate in and benefit significantly more than they currently do. 
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